Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104
出版年份 2020 全文链接
标题
Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-29
DOI
10.1038/s41388-020-1227-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis
- (2019) S. Pauliina Turunen et al. CELL DEATH AND DIFFERENTIATION
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response
- (2019) Yuning Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Interrupting the FGF19-FGFR4 axis to therapeutically disrupt cancer progression
- (2018) Liwei Lang et al. CURRENT CANCER DRUG TARGETS
- Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion.
- (2018) Zofia Piotrowska et al. Cancer Discovery
- FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
- (2018) Lixia Gao et al. ONCOGENE
- Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation
- (2017) Vittoria Massafra et al. PLoS One
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas
- (2017) Xiaochen Zhang et al. Thoracic Cancer
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells
- (2016) Zhi Yi Wan et al. HEPATOLOGY
- FGF19 Contributes to Tumor Progression in Gastric Cancer by Promoting Migration and Invasion
- (2016) Shuang Wang et al. ONCOLOGY RESEARCH
- Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
- (2016) Kai Hung Tiong et al. Oncotarget
- Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC
- (2015) K. R. Singleton et al. CANCER RESEARCH
- AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules
- (2015) S. M. Guichard et al. MOLECULAR CANCER THERAPEUTICS
- Increased Expression of FGF19 Contributes to Tumor Progression and Cell Motility of Human Thyroid Cancer
- (2015) Xiliang Zhang et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma
- (2015) Koos Koole et al. PATHOBIOLOGY
- FGF19 promotes progression of prostate cancer
- (2015) Hirotaka Nagamatsu et al. PROSTATE
- First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
- (2015) M. Hagel et al. Cancer Discovery
- US lung cancer trends by histologic type
- (2014) Denise Riedel Lewis et al. CANCER
- Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma
- (2014) Joseph Thaddeus Beck et al. CANCER TREATMENT REVIEWS
- Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression
- (2013) S. Feng et al. CANCER RESEARCH
- FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
- (2013) Alberto Peláez-García et al. PLoS One
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Metabolic Regulator βKlotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation
- (2010) Yongde Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started